You’re using a public version of DrugChatter with 1 free searches available. Register to unlock more free searches per day. CREATE FREE ACCOUNT

Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

When will generic yervoy become available?

At this point in time, there is no definitive answer as to when a generic version of Yervoy will become available. Yervoy, also known as ipilimumab, is a medication used to treat melanoma and is currently produced and marketed exclusively by Bristol Myers Squibb. The patent for Yervoy is set to expire in 2026 [1]. Once the patent expires, other companies will be able to produce and sell generic versions of the drug. However, it's important to note that it can take some time after a patent expires for generic versions of a drug to become available on the market.

It's worth noting that the process of bringing a generic drug to market can be complex and time-consuming. It involves several steps, including conducting clinical trials to demonstrate that the generic drug is equivalent to the brand-name drug in terms of safety and efficacy. This process can take several years to complete.

In summary, based on the available information, a generic version of Yervoy is not expected to be available until at least 2026. However, it's important to note that the exact timeline for the availability of a generic version of Yervoy is subject to change and will depend on a variety of factors, including the regulatory approval process.

[1] <>

Follow-up:   When can we expect generic Yervoy's release? What's the timeline for Yervoy's generic version? Is there an estimated date for Yervoy's generic launch?

DrugPatentWatch - Make Better Decisions
© thinkBiotech LLC 2004 - 2024. All rights reserved.